Bibliometrics Analysis on Applied Researches of Pharmacogenomics in Oncology

Rong XIANG,Yongxin JIN,Shiwu CHEN,Lining YANG
DOI: https://doi.org/10.14009/j.issn.1672-2124.2017.12.039
2017-01-01
Abstract:OBJECTIVE:To conduct bibliometrics analysis on studies of applied researches of pharmacogenomics in oncology , to investigate the current research situation in this field . METHODS: Web of Science was retrived , bibliometrics analysis was adopted to collect and analyze the collected studies from Jan .1st 1982-Apr.19th 2017 in terms of published year , nations and ( or ) regions , research institutes , journals , authors , research fields , cited frequencies , etc.RESULTS:3495 studies were involved finally , the number of studies presented an increasing trend during 1982-2013, which reached the top in 2013 and then gradually decreased .A total of 91 nations and (or) regions were involved , the number of studies in America was significantly more than that of other nations and ( or ) regions . 3987 research institutions were involved , the University of Chicago ranked the first .These studies were published on 876 journals, 987 studies (28.240%) were published on the top 10 journals ranked in number of published studies , the first was PHARMACOGENETICS AND GENOMICS; JOURNAL OF CLINICAL ONCOLOGY had the highest IF in the top 10 journals;16 JCR categories were involved in the top 10 journals.16807 authors were involved , 140 of which had published over 10 studies;among the top 10 authors ranked in the number of published studies , 7 were from America , the author ranked the first was Mcleod HL from the H .Lee Moffitt Cancer Center of America .These studies had involved 87 research fields , the top 4 were respectively medicine and pharmacology , oncology , gene genetics , biotechnology and applied microbiology .The 3495 studies had been cited for 94500 times, with an average cited frequency of 27.04 times, the correspondent authors of the top 3 studies ranked in cited frequency were respectively from Britain , Germany and France , the fourth to the tenth were from America; the top 1 study was "Systematic Identification of Genomic Markers of Drug Sensitivity in Cancer Cells".CONCLUSIONS: The applied researches of pharmacogenomics had achieved great progresses in oncology , yet in a slowdown in recent years , researchers have paid most attention on the relationship between gene expression and the sensitivity of antineoplastic agents ; at present , America owns the best research ability , our country also own well research ability , but there is still a certain gap between .
What problem does this paper attempt to address?